[Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000503:physiopathology; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D009203:Myocardial Infarction / Q000503:physiopathology; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D004176:Dipyridamole
Hämodynamische Wirkungen von Dipyridamol (Persantin) nach beta-Blockade bei Koronarinsuffizienz.